Multiple myeloma is a clonal malignancy that contributes to about 10% of hematological malignancies. Treatment ranges from alkylators and corticosteroids to autologous stem cell transplantation in the advanced stages of the disease. Knowing the details of available treatment modalities and recent advancements in cancer pharmacotherapy is crucial for positive patient outcomes. To gain detailed insights into “Multiple Myeloma,” join the reputed Oncologist specialty Dr.
Fadi Nasr in our exclusive webinar on 13 th February 2024, 11:00 AM IST . Stay tuned! Suggested for you FDA Approves Teclistamab-cqyv for Refractory Multiple Myeloma New Therapy for Hard-to-Treat Multiple Myeloma Vaccine-induced Immune Response in Multiple Myeloma and B-cell Lymphoma Patients ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy,…
